StockNews.com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)

StockNews.com initiated coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research report released on Saturday morning. The brokerage issued a sell rating on the stock. Moleculin Biotech Price Performance Shares of Moleculin Biotech stock opened at $2.37 on Friday. Moleculin Biotech has a 12 month low of $2.12 and a 12 […]

Leave a Reply

Your email address will not be published.

Previous post Marine Petroleum Trust (NASDAQ:MARPS) Earns Hold Rating from Analysts at StockNews.com
Next post Noah Feldman: The problem with banning legacy admissions